Literature DB >> 2546698

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

W S Colucci1, J P Ribeiro, M B Rocco, R J Quigg, M A Creager, J D Marsh, D F Gauthier, L H Hartley.   

Abstract

The mechanism responsible for the attenuated heart rate (HR) response to exercise in patients with congestive heart failure (CHF) was investigated in 46 normal subjects and 59 patients with CHF stratified by peak exercise oxygen consumption (VO2). The peak exercise HR and the increment in HR from rest to peak exercise were decreased in CHF patients, and both correlated strongly with peak VO2 (r = 0.810, p less than 0.0001; r = 0.863, p less than 0.0001, respectively). Peak exercise norepinephrine level (NE) and the increment in NE from rest to peak exercise were not attenuated in CHF patients. Resting NE was elevated in CHF patients and correlated inversely with peak VO2 (r = -0.595, p less than 0.001). However, no significant correlation occurred between peak VO2 and either peak exercise NE or the exercise increment in NE. The ratio of the exercise increments in HR and NE, and indirect index of sinoatrial node sympathetic responsiveness, was markedly reduced in CHF patients and was inversely related to the severity of exercise impairment. Likewise, the HR response to a graded isoproterenol infusion was markedly reduced in CHF patients. Age-matching of normal subjects and CHF patients did not affect the foregoing observations. Infusion of CHF patients with the phosphodiesterase inhibitor milrinone caused a significant increase in the ratio of the exercise increments in HR and NE. These data strongly suggest that the attenuated HR response to exercise in CHF patients is due, at least in part, to postsynaptic desensitization of the beta-adrenergic receptor pathway.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546698     DOI: 10.1161/01.cir.80.2.314

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  67 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Autonomic nervous control of the heart rate response to dynamic incremental exercise: evaluation of the Rosenblueth-Simeone model.

Authors:  J P Ribeiro; J M Ibáñez; R Stein
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 4.  Chronotropic Incompetence During Exercise in Type 2 Diabetes: Aetiology, Assessment Methodology, Prognostic Impact and Therapy.

Authors:  Charly Keytsman; Paul Dendale; Dominique Hansen
Journal:  Sports Med       Date:  2015-07       Impact factor: 11.136

5.  Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.

Authors:  K K A Witte; J G F Cleland; A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 6.  Autonomic changes in patients with heart failure and in post-myocardial infarction patients.

Authors:  M P Frenneaux
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Prolonged strenuous exercise alters the cardiovascular response to dobutamine stimulation in male athletes.

Authors:  Robert C Welsh; Darren E R Warburton; Dennis P Humen; Dylan A Taylor; Jonathon McGavock; Mark J Haykowsky
Journal:  J Physiol       Date:  2005-09-08       Impact factor: 5.182

Review 8.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

Review 9.  Prevalence and management of chronotropic incompetence in heart failure.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 10.  Physiology of the abnormal response of heart failure patients to exercise.

Authors:  Alain Cohen-Solal; Florence Beauvais; Jean Yves Tabet
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.